EUVIMEDEUVIMED entdecken
Netzwerk-MetaanalyseOpen Access

Efficacy and Safety of Direct Oral Anticoagulants for Stroke Prevention in Older Patients With Atrial Fibrillation: A Network Meta‐Analysis of Randomized Controlled Trials

Donna Shu-Han Lin iD, Hao-Yun Lo, Kuan-Chih Huang, Ting-Tse Lin, Jen-Kuang Lee iD

Journal of the American Heart Association · 05.12.2023 · 12 (23)

DOI: 10.1161/jaha.123.030380 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift Journal of the American Heart Association, erschienen am 05.12.2023. Verfasst von Donna Shu-Han Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology Department of Internal Medicine Shin Kong Wu Ho-Su Memorial Hospital Taipei Taiwan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Stroke, Embolism. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although older patients with atrial fibrillation are at heightened risk of thromboembolic and bleeding events, their optimal treatment choice remains uncertain. Methods and Results This meta‐analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines. We searched the PubMed, EMBASE, and Cochrane databases for randomized controlled trials that compared thromboembolic or bleeding outcomes between a direct oral anticoagulant (DOAC) and a vitamin K antagonist (VKA) and reported outcomes for patients aged ≥75 years with atrial fibrillation. The efficacy outcome was the composite of stroke and systemic embolism. Safety outcomes included major bleeding, any clinically relevant bleeding, and intracranial hemorrhage. Each DOAC and VKA was compared pairwise in a network meta‐analysis. High‐ and low‐dose regimens and factor IIa and Xa inhibitors were also compared. Seven randomized controlled trials were included in the analysis. Stroke and systemic embolism risks did not differ significantly among DOACs. There were no significant differences in major bleeding between each DOAC and VKA. Intracranial hemorrhage risk was significantly lower with dabigatran, apixaban, and edoxaban than with VKA and rivaroxaban, which had similar risks. High‐dose regimens led to lower risks of stroke or systemic embolism compared with VKA and low‐dose regimens, with both doses having similar bleeding risks.

Conclusions

In patients aged ≥75 years with atrial fibrillation, DOACs were associated with fewer thromboembolic events compared with VKA, whereas dabigatran, apixaban, and edoxaban were associated with lower risks of intracranial hemorrhage compared with VKA and rivaroxaban. Registration URL: www.crd.york.ac.uk/prospero/ . Unique identifier: CRD42022329557.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationStrokeEmbolismHumansAgedRivaroxabanDabigatranRandomized Controlled Trials as TopicAnticoagulantsHemorrhageIntracranial HemorrhagesAdministration, OralPyridinesThiazoles

Stichwörter der Autor:innen

atrial fibrillationbleedingdirect oral anticoagulantsold agestroke

Substanzen

RivaroxabanDabigatranAnticoagulantsedoxabanPyridinesThiazoles

Autor:innen und Institutionen

  • Division of Cardiology Department of Internal Medicine Shin Kong Wu Ho-Su Memorial Hospital Taipei Taiwan.
  • Division of Cardiology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.
  • Division of Cardiology Department of Internal Medicine National Taiwan University Hospital Hsin-Chu Branch Hsinchu Taiwan.
  • Department of Internal Medicine National Taiwan University College of Medicine Taipei Taiwan.
  • Department of Laboratory Medicine National Taiwan University College of Medicine Taipei Taiwan.
  • Cardiovascular Center National Taiwan University Hospital Taipei Taiwan.

ORCID-Profile: Donna Shu-Han Lin, Jen-Kuang Lee

Zitieren

APA

Lin, D. S., Lo, H. Y., Huang, K. C., Lin, T. T., & Lee, J. K. (2023). Efficacy and Safety of Direct Oral Anticoagulants for Stroke Prevention in Older Patients With Atrial Fibrillation: A Network Meta‐Analysis of Randomized Controlled Trials. Journal of the American Heart Association, 12(23). https://doi.org/10.1161/jaha.123.030380

Vancouver

Lin DS, Lo HY, Huang KC, Lin TT, Lee JK. Efficacy and Safety of Direct Oral Anticoagulants for Stroke Prevention in Older Patients With Atrial Fibrillation: A Network Meta‐Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 2023;12(23). doi:10.1161/jaha.123.030380

BibTeX
@article{Lin2023,
  author = {Lin, Donna Shu-Han and Lo, Hao-Yun and Huang, Kuan-Chih and Lin, Ting-Tse and Lee, Jen-Kuang},
  title = {Efficacy and Safety of Direct Oral Anticoagulants for Stroke Prevention in Older Patients With Atrial Fibrillation: A Network Meta‐Analysis of Randomized Controlled Trials},
  journal = {Journal of the American Heart Association},
  year = {2023},
  volume = {12},
  number = {23},
  doi = {10.1161/jaha.123.030380}
}
Kostenlos starten →